Journal article

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

To report 24-month vision and fluorescein angiographic outcomes from trials evaluating photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, Ga) in patients with subfoveal choroidal neovascularization (CNV) caused by age-related macular degeneration (AMD).

    Keywords: Photochemotherapy


    • EPFL-ARTICLE-163501

    Record created on 2011-02-16, modified on 2016-08-09


  • There is no available fulltext. Please contact the lab or the authors.

Related material